Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Non-Current Debt (2020 - 2024)

Bio Essence (BIOE) has 5 years of Non-Current Debt data on record, last reported at $1.4 million in Q1 2024.

  • For Q1 2024, Non-Current Debt rose 6064.53% year-over-year to $1.4 million; the TTM value through Mar 2024 reached $1.4 million, up 6064.53%, while the annual FY2023 figure was $15221.0, 40.45% down from the prior year.
  • Non-Current Debt reached $1.4 million in Q1 2024 per BIOE's latest filing, up from $15221.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $1.4 million in Q1 2024 and bottomed at $14549.0 in Q2 2021.
  • Average Non-Current Debt over 5 years is $148723.1, with a median of $30355.0 recorded in 2022.
  • Peak YoY movement for Non-Current Debt: plummeted 83.48% in 2022, then soared 6064.53% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $212750.0 in 2020, then tumbled by 82.18% to $37918.0 in 2021, then tumbled by 32.59% to $25561.0 in 2022, then plummeted by 40.45% to $15221.0 in 2023, then skyrocketed by 8905.62% to $1.4 million in 2024.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $1.4 million in Q1 2024, $15221.0 in Q4 2023, and $17288.0 in Q3 2023.